Table 1.

Inhibition of Cryoglobulin/RF-Mediated Skin Vasculitis in FcRγ −/− Mice

FcRγ 6-19 No. Serum IgG3 (mg/mL) Ear Lesions Kidney Lesions Serum BUN (mg/dL)
+/− +  11  8.42 ± 4.17* 11/11 11/11 150.0 ± 69.0* 
 −  3  <0.01  0/3 0/3  20.0 ± 2.2  
−/−  +  12  8.28 ± 2.92 0/12  12/12  153.1 ± 99.9  
 −  <0.01  0/3  0/3  19.9 ± 7.7 
FcRγ 6-19 No. Serum IgG3 (mg/mL) Ear Lesions Kidney Lesions Serum BUN (mg/dL)
+/− +  11  8.42 ± 4.17* 11/11 11/11 150.0 ± 69.0* 
 −  3  <0.01  0/3 0/3  20.0 ± 2.2  
−/−  +  12  8.28 ± 2.92 0/12  12/12  153.1 ± 99.9  
 −  <0.01  0/3  0/3  19.9 ± 7.7 

FcRγ +/− or FcRγ −/− mice were inoculated with 6-19 hybridoma cells as described in Materials and Methods. Blocks of the ear and kidney as well as blood samples were collected when the FcRγ +/− mice exhibited skin purpura (7 to 12 days after 6-19 administration).

*

Values for serum IgG3 and BUN represent the mean ± SD and were determined at time of death.

Criteria for positive lesions are described in Materials and Methods.

Close Modal

or Create an Account

Close Modal
Close Modal